Announce your event here
5th Annual Biosimilars & Biobetters Congress
2018-04-16 to 2018-04-17
London, UK

Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:
Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics

Free Pre-Congress Live Webinars

Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and RafaƂ Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT

Register today for free:

Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT

Register today for free:

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact

View Agenda here: link

20th Symposium on Infections in the Immunocompromised Host
2018-06-17 to 2018-06-19
Athens, Greece

We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics,  infections in transplant recipients,  invasive fungal infections and resistance,  treatment of multi-resistant bacteria, infectious complications in immunocompromised children,  life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts,  prophylaxis and treatment of viral infections in immunocompromised hosts, and others. link

RNA Therapeutics: From Base Pairs to Bedsides
2018-06-28 to 2018-06-29
UMass Medical School, Worcester, MA, USA
We live in an exciting time for the RNA research community. Throughout the latter half of the 20th century, we believed that RNA’s primary role was to intermediate between DNA and protein. Over the last three decades, those long-held beliefs have been shattered. From ncRNAs to RNAi, from CRISPR to circular RNAs, we have witnessed astonishing discoveries and equally amazing translation of these breakthroughs to therapy. Come and join the discussion as we explore the era of RNA therapeutics during our inaugural conference at the RNA Therapeutics Institute. link

4th European NF-kB subunit meeting
2018-10-08 to 2018-10-10
Grasse, French Riviera
The ethos of the workshop is to bring together researchers interested in the biology of the NF-kB subunits from all over Europe (and sometimes beyond) in an informal and relaxed setting to present and discuss unpublished work from their laboratories. We encourage talks from scientists at all stages of their careers and our aim is to provide an opportunity for as many as possible of those who wish to present their data to be able to do so.
The subject areas covered at the workshops are diverse. These include fundamental mechanistic studies of the NF-kB proteins function as transcription factors, including proteomic analysis of subunit post-translational modifications and genome wide analysis of genetic targets through ChIP Seq and RNA Seq analysis. Another focus of the workshops is the physiological and pathological roles of the NF-kB subunits. Data presented includes those using mice and other model systems, together with analysis of normal and diseased human tissues. We have sessions devoted to the role of NF-kB in the immune and inflammatory responses as well as its role in cancer.

The meeting will be held in Grasse, considered the world’s capital of perfume and was made town of art and history. The venue “Village Vacances les Cèdres” is located at 800m from Grasse downtown in the heart of a tree and flower park of 2,5 ha, a favorable framework for scientific exchange and sharing. The venue is near the international airport of Nice (south east of France), and a shuttle service will be organized to drive you to the workshop.

This is a very special occasion for us to meet and discuss and we hope that many of you will attend the conference and share this great scientific time gathering the European NF-kB community.

We look forward to seeing you in France! link